Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DreaMS - Development of Digital Biomarkers in Multiple Sclerosis - Validation Study 1

NCT05009160 is registered in ClinicalTrials.gov with Research Center for Clinical Neuroimmunology and Neuroscience Basel as lead sponsor.

NCT NCT05009160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05009160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DreaMS - Development of Digital Biomarkers in Multiple Sclerosis - Validation Study 1
Lead sponsor
Research Center for Clinical Neuroimmunology and Neuroscience Basel
Phase
Observational
Overall status
Active, not recruiting
Start date
March 30, 2022
Completion date
March 31, 2027
Enrollment
300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis